Drugs / CKDB-501B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05428930 | Jun → Oct 2022 | — | CKD Bio Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKDB-501B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05428930 ↗ |
| Route | Intramuscular | “Intramuscular injection CKDB-501B” NCT05428930 ↗ |